MYndspan and BIOS Health Partner to Bring Precision Neuroscience to Consumers “`

0fd90dac710de3136a142e4257dd0858 MYndspan and BIOS Health Partner to Make Consumer-Scale Precision Neuroscience a Reality

LONDON, Feb. 3, 2025 – MYndspan, a leader in consumer brain health technology, and BIOS Health, a specialist in real-time neural data analysis and treatment optimization, have formed a partnership to expand the reach and impact of precision neuroscience. This collaboration integrates MYndspan’s Magnetoencephalography (MEG)-based brain scans with BIOS Health’s proprietary neural data and AI platform, making advanced neural insights and interventions more widely available.

Similar to how DNA sequencing revolutionized personalized medicine, AI-driven analysis of neural signals is transforming our understanding of the brain and enabling new personalized medicine approaches. BIOS Health and MYndspan utilize distinct yet complementary methods for analyzing neural signals. MYndspan offers consumers neural insights through non-invasive MEG scans—the most advanced technology for real-time brain activity recording and analysis, previously largely confined to research and specialized clinical settings. BIOS Health, on the other hand, employs real-time neural biomarkers to personalize treatment delivery for neuromodulation devices.

“This collaboration represents a significant step forward in how we assess, understand, and improve brain health,” stated Caitlin Baltzer, Co-Founder and CEO of MYndspan. “By combining advanced MEG technology and our brain scans with BIOS Health’s innovative data infrastructure, we’re not only making cutting-edge brain health insights accessible to consumers but also providing clinicians with enhanced tools to understand and treat neurological conditions.”

“MYndspan’s consumer-focused MEG technology complements BIOS Health’s real-time neural data infrastructure perfectly,” noted Emil Hewage, CEO of BIOS Health. “This partnership will accelerate the development and implementation of precision brain health tools. By combining our strengths, we can empower clinicians to make faster, more accurate decisions and individuals to actively manage their brain health.”

A recent study published in showed MYndspan’s ability to identify markers of both healthy and accelerated brain aging, opening new avenues for understanding neurodegenerative diseases. This partnership will extend these research findings to practical applications, benefiting both individuals and healthcare systems.

By combining user-friendly technology with advanced clinical-grade machine learning techniques, MYndspan and BIOS Health are working towards transforming brain health for millions.

About MYndspan:
MYndspan is dedicated to improving access to preventive and proactive brain health and is the world’s first company to offer non-invasive Magnetoencephalography (MEG) technology directly to consumers. MEG, typically only available in research and specialized clinical settings, is the most advanced method for recording and evaluating brain activity during active functioning.

MYndspan’s brain health assessment technology is based on 35 years of research and 300+ peer-reviewed studies, aiming to become a standard preventive health measure to support better brain health for everyone, including early detection of neurodegenerative conditions and functional abnormalities from invisible traumatic brain and stress injuries such as concussions and PTSD.

Website:

About BIOS Health:
BIOS Health’s AI data platform uses real-time neural insights to personalize neuromodulation dosing within minutes. BIOS’s ability to precisely correlate nerve activity with physiological responses could unlock a new generation of treatments across various therapeutic areas, including cardiac, respiratory, and neurological diseases.

BIOS was co-founded by Cambridge University researchers Emil Hewage and Oliver Armitage, and its advisors include Oxford University Professors David Paterson and Tim Denison, Candel Therapeutics CEO Paul Peter Tak, and IQVIA VP of Genomic and Precision Medicine Joanne Hackett

Website:

SOURCE MYndspan

elong